Related Experiment Video

Updated: Mar 23, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

896

Amiodarone disrupts thyroid hormone homeostasis and impairs myogenic progression and locomotor function in zebrafish

Juhi Vaishnav1, Abhinav Upadhyay1, Arya Bhatt1

  • 1Dr. Vikram Sarabhai Institute of Cell and Molecular Biology, The Maharaja Sayajirao University of Baroda, Vadodara, Gujarat, 390002, India.

Journal of Muscle Research and Cell Motility
|March 22, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
AmiodaroneEmbryogenesisMuscle developmentNotch signalingThyroid hormone receptor

More Related Videos

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K
CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts
06:52

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

4.2K

Related Experiment Videos

Last Updated: Mar 23, 2026

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
06:15

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish

Published on: August 16, 2024

896
A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

10.5K
CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts
06:52

CRISPR-Cas9-Mediated Precise Knock-In Edits in Zebrafish Hearts

Published on: September 13, 2022

4.2K

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.8K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.8K

Articles linked to this work by shared authors, journal, and citation graph.

Amiodarone-induced disruption of thyroid hormone signaling derails patterning and epithelial-mesenchymal dynamics during chick hindlimb development.

Zoology (Jena, Germany)·2026

Amiodarone-mediated thyroid hormone disruption induces mitochondrial apoptosis and G1 arrest during chick embryogenesis.

Developmental biology·2026

4-FPAC-Modulated Tumor-Associated Macrophage Conditioned Media Suppresses Malignant Phenotypes and Promotes Cell-Cycle Arrest and Apoptosis in NSCLC.

Journal of biochemical and molecular toxicology·2026

Amiodarone disrupts thyroid hormone signaling networks governing early heart development in the chick embryo.

General and comparative endocrinology·2025

Thyroid hormone receptor blockade by amiodarone disrupts angiogenesis via VEGFα, WNT7A, BMP, and PI3K/AKT pathways in chick embryo vascular development.

Developmental dynamics : an official publication of the American Association of Anatomists·2025

Thyroid Hormone Deficiency Disrupts Embryonic Ventral Body Wall Development and Myogenesis With Partial Recovery Following LevothyroxineTherapy.

Birth defects research·2025

Sex-dependent regulation of cholinergic responses in the mouse colon: functional evidence for reduced acetylcholinesterase-dependent control and nitrergic modulation in females.

Journal of muscle research and cell motility·2026

Cloning and characterization of intermediate Homer1E of human skeletal muscle.

Journal of muscle research and cell motility·2026

Temperature dependence of activation of thick and thin filaments in skeletal and cardiac muscles.

Journal of muscle research and cell motility·2026

Hypertrophic cardiomyopathy-linked Tnnc1 variants are associated with distinct myopathic changes in slow skeletal muscle of mice.

Journal of muscle research and cell motility·2026

A novel pulley-vest model enables progressive resistance exercise in rats without tail loading.

Journal of muscle research and cell motility·2026

Sex-dependent responses to moderate/low-intensity swimming and loaded ladder-climbing resistance exercise in mdx mice.

Journal of muscle research and cell motility·2026

Optimisation of in vitro assays for accurate risk assessment of T-cell responses to biologics with potential immune liabilities.

Archives of toxicology·2026

From hematuria warning to precision immunotherapy: an AI-assisted cross-platform analysis of bladder cancer information on social media.

Frontiers in medicine·2026

Efficacy and safety of novel VAC-Stent in management of upper gastrointestinal post-surgical leaks: results from a large multicenter study in tertiary referral centers.

Gastrointestinal endoscopy·2026

Disentangling Between- and Within-Person Effects of HIV PrEP and Treatment Attitudes on Condom Use and Bacterial STIs Among Sexual Minority Men.

AIDS and behavior·2026

MeVO: To Treat or Not To Treat? Review of the Latest Evidence.

Current neurology and neuroscience reports·2026

A simulation of recreational and addictive methamphetamine use on the integrity of the blood-brain barrier endothelium using an in vitro BBB model.

Tissue barriers·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us